Table: Shin Nippon Biomedical - 9-MTH group results

Shin Nippon Biomedical Laboratories

31/01/2023 06:00

Jan 31 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             16.37               12.95            25.00    
                 (+26.5 pct)         (+24.2 pct)      (+40.9 pct) 
  Operating          3.78                3.30             5.46    
                 (+14.6 pct)        (+103.0 pct)      (+30.1 pct) 
  Recurring          6.88                4.68             8.43    
                 (+46.9 pct)        (+184.5 pct)      (+19.1 pct) 
  Net                4.35                5.25             5.31    
                 (-17.1 pct)        (+255.4 pct)      (-25.5 pct) 
  EPS            104.52 yen          126.05 yen       127.54 yen  
  Ann Div                             40.00 yen        50.00 yen  
  -Q2 div         20.00 yen              NIL                      
  -Q4 div                             40.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T